Published in PLoS One on March 23, 2017
Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet (2010) 4.46
Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase. J Clin Invest (1996) 2.21
Lipoprotein-associated phospholipase A2 as a target of therapy. Curr Opin Lipidol (2005) 1.27
Optimal cutoff values for overweight: using body mass index to predict incidence of hypertension in 18- to 65-year-old Chinese adults. J Nutr (2008) 1.10
The Val279Phe variant of the lipoprotein-associated phospholipase A2 gene is associated with catalytic activities and cardiovascular disease in Korean men. J Clin Endocrinol Metab (2006) 1.08
Oxidized low-density lipoprotein increases superoxide production by endothelial nitric oxide synthase by inhibiting PKCalpha. Cardiovasc Res (2005) 1.03
Carriage of the V279F null allele within the gene encoding Lp-PLA₂ is protective from coronary artery disease in South Korean males. PLoS One (2011) 0.99
Effects of G994T in the Lp-PLA2 gene on the plasma oxidized LDL level and carotid intima-media thickness in Japanese: the Shimane study. Am J Hypertens (2009) 0.91
Burst production of superoxide anion in human endothelial cells by lysophosphatidylcholine. Atherosclerosis (1999) 0.90
Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications. World J Cardiol (2015) 0.87
Blood pressure-lowering effect of Korean red ginseng associated with decreased circulating Lp-PLA2 activity and lysophosphatidylcholines and increased dihydrobiopterin level in prehypertensive subjects. Hypertens Res (2016) 0.84
Effects of V279F in the Lp-PLA(2) gene on markers of oxidative stress and inflammation in Koreans. Clin Chim Acta (2010) 0.84
Association of serum lycopene and brachial-ankle pulse wave velocity with metabolic syndrome. Metabolism (2010) 0.82
Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional study. Lipids Health Dis (2013) 0.81
Elevated circulating levels of lipoprotein-associated phospholipase A2 in obese children. Clin Chem Lab Med (2015) 0.81
Association between arterial stiffness and serum L-octanoylcarnitine and lactosylceramide in overweight middle-aged subjects: 3-year follow-up study. PLoS One (2015) 0.80
Prevalence of Major Cardiovascular Risk Factors and Cardiovascular Disease in Women in China: Surveillance Efforts. Biomed Environ Sci (2016) 0.78
Carriage of the V279F homozygous genotype, a rare allele, within the gene encoding Lp-PLA2 leads to changes in circulating intermediate metabolites in individuals without metabolic syndrome. J Atheroscler Thromb (2014) 0.78
Expression of Lipoprotein associated phospholipase A2 enzyme in medical undergraduate students with metabolic syndrome. Diabetes Metab Syndr (2015) 0.78
Blood pressure-lowering effect of Korean red ginseng associated with decreased circulating Lp-PLA2 activity and lysophosphatidylcholines and increased dihydrobiopterin level in prehypertensive subjects. Hypertens Res (2016) 0.84
Altered plasma lysophosphatidylcholines and amides in non-obese and non-diabetic subjects with borderline-to-moderate hypertriglyceridemia: a case-control study. PLoS One (2015) 0.76
EPHA6 rs4857055 C > T polymorphism associates with hypertension through triglyceride and LDL particle size in the Korean population. Lipids Health Dis (2017) 0.75
Relationship between changes in polyunsaturated fatty acids and aging-related arterial stiffness in overweight subjects 50 years or older over a 3-year period. J Clin Lipidol (2016) 0.75
Hyporesponsiveness of natural killer cells and impaired inflammatory responses in critically ill patients. BMC Immunol (2017) 0.75
Influence of estrogen-related receptor γ (ESRRG) rs1890552 A > G polymorphism on changes in fasting glucose and arterial stiffness. Sci Rep (2017) 0.75
Associations between metabolomic-identified changes of biomarkers and arterial stiffness in subjects progressing to impaired fasting glucose. Clin Endocrinol (Oxf) (2015) 0.75
Enriching plausible new hypothesis generation in PubMed. PLoS One (2017) 0.75
Metabolites distinguishing visceral fat obesity and atherogenic traits in individuals with overweight. Obesity (Silver Spring) (2016) 0.75
Effects of weight loss using supplementation with Lactobacillus strains on body fat and medium-chain acylcarnitines in overweight individuals. Food Funct (2017) 0.75
A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients. PLoS One (2017) 0.75